GlaxoSmithKline PLC — Remuneration Information 2013

Jul 1, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3225I

GlaxoSmithKline PLC

01 July 2013

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 28 June 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.39 per Ordinary Share, and notional ADSs at a price of $49.95 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2013 to 30 June 2013:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,593.045
Professor Sir Roy Anderson	552.929
Dr Stephanie Burns		462.187
Stacey Cartwright	438.530
Lynn  Elsenhans		831.937
Judy Lewent		391.854
Sir Deryck Maughan		1,083.369
Dr Daniel Podolsky		873.536
Tom de Swaan	514.796
Jing Ulrich		291.379
Hans Wijers	324.131
Sir Robert Wilson	477.501

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2013.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 July 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZFLFBXDFZBBE